Bifurcated stent and delivery system

Abstract
A bifurcated stent includes a first stent section and a second stent section. The first stent section is balloon expandable, has an unexpanded configuration, an expanded configuration, and a tubular wall defining a secondary opening. The secondary stent section is self-expanding and an end of the secondary stent section is engaged to a portion of the tubular wall of the primary stent section defining the secondary opening. The secondary stent section has an unexpanded configuration with a first length and an expanded configuration with a second length where the first length is less than the second length. The secondary stent section is expanded to the expanded configuration after the primary stent section is expanded to the expanded configuration. The secondary stent section forms a portion of the tubular wall of the primary stent section in the unexpanded configuration.
Description
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH

Not Applicable


BACKGROUND OF THE INVENTION

Stents, grafts, stent-grafts, vena cava filters and similar implantable medical devices, collectively referred to hereinafter as stents, are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. Stents may be implanted in a variety of body lumens or vessels such as within the vascular system, urinary tracts, bile ducts, etc. Stents may be used to reinforce body vessels and to prevent restenosis following angioplasty in the vascular system. They may be self-expanding or expanded by an internal radial force, such as when mounted on a balloon.


Stents are generally tubular devices for insertion into body lumens. Balloon expandable stents require mounting over a balloon, positioning, and inflation of the balloon to expand the stent radially outward. Self-expanding stents expand into place when unconstrained, without requiring assistance from a balloon. A self-expanding stent is biased so as to expand upon release from the delivery catheter. Some stents may be characterized as hybrid stents which have some characteristics of both self-expandable and balloon expandable stents.


Stents may be constructed from a variety of materials such as stainless steel, Elgiloy, nitinol, shape memory polymers, etc. Stents may also be formed in a variety of manners as well. For example a stent may be formed by etching or cutting the stent pattern from a tube or section of stent material; a sheet of stent material may be cut or etched according to a desired stent pattern whereupon the sheet may be rolled or otherwise formed into the desired tubular or bifurcated tubular shape of the stent; one or more wires or ribbons of stent material may be braided or otherwise formed into a desired shape and pattern.


A vessel having a stenosis may be viewed as an inwardly protruding arcuate addition of hardened material to a cylindrical vessel wall, where the stenosed region presents a somewhat rigid body attached along, and to, the elastic wall. The stenosis presents resistance to any expansion of the vessel in the region bridged by the stenosis. Stenoses vary in composition, for example, in the degree of calcification, and therefore vary in properties as well.


A stent may be used to provide a prosthetic intraluminal wall e.g. in the case of a stenosis to provide an unobstructed conduit for blood in the area of the stenosis. An endoluminal prosthesis comprises a stent which carries a prosthetic graft layer of fabric and is used e.g. to treat an aneurysm by removing the pressure on a weakened part of an artery so as to reduce the risk of embolism, or of the natural artery wall bursting. Typically, a stent or endoluminal prosthesis is implanted in a blood vessel at the site of a stenosis or aneurysm by so-called “minimally invasive techniques” in which the stent is compressed radially inwards and is delivered by a catheter to the site where it is required through the patient's skin or by a “cut down” technique in which the blood vessel concerned is exposed by minor surgical means. When the stent is positioned at the correct location, the catheter is withdrawn and the stent is caused or allowed to re-expand to a predetermined diameter in the vessel.


U.S. Pat. No. 4,886,062 discloses a vascular stent which comprises a length of sinuous or “zig-zag” wire formed into a helix; the helix defines a generally cylindrical wall which, in use, constitutes a prosthetic intraluminal wall. The sinuous configuration of the wire permits radial expansion and compression of the stent; U.S. Pat. No. 4,886,062 discloses that the stent can be delivered percutaneously and expanded in situ using a balloon catheter.


U.S. Pat. No. 4,733,665 discloses an expandable intraluminal graft which is constituted by a tubular member formed from a plurality of intersecting elongate members which permit radial expansion and compression of the stent.


EP-A-0556850 discloses an intraluminal stent which is constituted by a sinuous wire formed into a helix; juxtaposed apices of the wire are secured to one another so that each hoop of the helix is supported by its neighboring hoops to increase the overall strength of the stent and to minimize the risk of plaque herniation; in some embodiments the stent of EP-A-0556850 further comprises a tubular graft member to form an endoluminal prosthesis.


The devices cited above are generally satisfactory for the treatment of aneurysms, stenoses and other angeological diseases at sites in continuous unbifurcated portions of arteries or veins.


Within the vasculature however it is not uncommon for stenoses to form at a vessel bifurcation. A bifurcation is an area of the vasculature or other portion of the body where a first (or parent) vessel is bifurcated into two or more branch vessels. Where a stenotic lesion or lesions form at such a bifurcation, the lesion(s) can affect only one of the vessels (i.e., either of the branch vessels or the parent vessel) two of the vessels, or all three vessels. Many prior art stents however are not wholly satisfactory for use where the site of desired application of the stent is juxtaposed or extends across a bifurcation in an artery or vein such, for example, as the bifurcation in the mammalian aortic artery into the common iliac arteries.


In the case of an abdominal aortic aneurysm (“AAA”) in the infrarenal portion of the aorta which extends into one of the common iliac arteries, the use of one of the prior art prosthesis referred to above across the bifurcation into the one iliac artery will result in obstruction of the proximal end of the other common iliac artery; by-pass surgery is therefore required to connect the one iliac artery in juxtaposition with the distal end of the prosthesis to the other blocked iliac artery. It will be appreciated by a person skilled in the art that it is desirable to avoid surgery wherever possible; the requirement for by-pass surgery associated with the use of the prior art prosthesis in juxtaposition with a bifurcation in an artery therefore constitutes a significant disadvantage.


Another example of a vessel bifurcation is the left and right common carotid arteries. These arteries are the principal arteries of the head and neck. Both of the common carotid arteries are quite similar and divide at a carotid bifurcation or bulb into an external carotid artery and an internal carotid artery. In the region of the carotid bulb and the ostium of the internal carotid artery, stenoses present a particular problem for carotid stenting due to the large tapering of the vessel interior from the common carotid artery (both the left and the right) to the internal carotid artery. The region of the carotid bifurcation or bulb happens to be where stenoses most often occur, particularly in the region of the ostium to the internal carotid artery in both of the carotid arteries.


Embodiments of the present invention relate to endoluminal prosthesis (stents) that may be utilized in the region of a bifurcation of vessels. The present invention also embraces stent connecting means for connecting a stent (e.g. a stent which forms part of an endoluminal prosthesis or bifurcated stent) to another stent or portion thereof. Some embodiments of the invention are directed to designs of bifurcated stents and their method of manufacture, as well as apparatuses and methods for introducing prostheses to the vasculature and methods of treating angeological diseases.


All US patents and applications and all other published documents mentioned anywhere in this application are incorporated herein by reference in their entirety.


Without limiting the scope of the invention a brief summary of some of the claimed embodiments of the invention is set forth below. Additional details of the summarized embodiments of the invention and/or additional embodiments of the invention may be found in the Detailed Description of the Invention below.


A brief abstract of the technical disclosure in the specification is provided as well only for the purposes of complying with 37 C.F.R. 1.72. The abstract is not intended to be used for interpreting the scope of the claims.


BRIEF SUMMARY OF THE INVENTION

The present invention includes many different embodiments. Various embodiments of the invention are directed to designs of bifurcated stents and/or the methods and apparatuses utilized to deliver a bifurcated stent to a bifurcation site.


In at least one embodiment, the invention is directed to a bifurcated stent delivery system that includes a unique catheter assembly having a primary and secondary guide wire wherein the secondary guide wire diverges away from the primary guide wire through a split in the catheter housing. The split allows the catheter to deliver a bifurcated stent center first.


The bifurcated stent is an embodiment of the invention that comprises a primary stent section and a secondary stent section. When used with the above catheter, the primary section is delivered center first through the split in the catheter housing. The secondary stent section is then delivered into a secondary vessel according to the predelivery placement of the secondary guide wire.


The bifurcated stent may be a one piece design where the primary and secondary sections are engaged to one another prior to delivery or it may be a two-piece design where the primary and secondary sections are separate and distinct stent bodies that may be optionally engaged to one another during delivery. The primary and secondary stent sections are preferably self-expandable but may be either self-expandable or balloon expandable independent of one another.


In another embodiment of the invention a self-expandable bifurcated stent may be delivered by a catheter having a retractable outer sheath or sleeve that retains the bifurcated stent in a collapsed state. When the sheath is retracted the primary stent section is exposed to self-expand. In at least one embodiment the secondary stent section remains in the collapsed state within the expanded primary stent section until a pusher mechanism is actuated to cause the secondary stent section to self-expand.


In at least one embodiment of the invention, a catheter system is employed wherein two guide wires and at least two balloons are employed to deliver a single piece bifurcated stent. In at least one embodiment, the balloons are substantially parallel to one another and the bifurcated stent is placed over both balloons with a single balloon extending into each section of the bifurcated stent. As a result, the stent branches may be independently guided and expanded. Where a portion of the stent is disposed about both balloons, in some embodiments the balloons may be linked together with a restrictive collar or band of material that will limit the expandability of the balloons to prevent the stent from being over expanded, however in other embodiments the collar may be omitted.


In some embodiments of the invention the catheter may also employ two angioplasty balloons that are initially advanced to the bifurcation site prior to stent delivery.


In at least one embodiment of the invention the bifurcated stent to be delivered is a one piece bifurcation stent comprising a primary stent section and a secondary stent section, the secondary stent section is linked to the primary stent section with one or more flexible linkage members. In at least one embodiment at least four linkage members connect the stent sections. Preferably, the flexible members are substantially S-shaped and/or are selectively annealed.


In at least one embodiment, the invention is directed to a single piece bifurcated stent wherein the primary stent section and the secondary stent section are engaged together by a linkage which allows the bifurcated stent to form distinct support structures on either side of the carina of a bifurcation. Preferably, the linkage comprises at least one strut or connecting member that is shared by both stent sections. In at least one embodiment the linkage is constructed from a selectively annealed metal or other material.


In the various embodiments of the invention portions of a given catheter and/or stent may include radiopaque materials to aid in visual inspection and/or placement of the devices such as during fluoroscopy.


Additional details and/or embodiments of the invention are discussed below.





BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS

A detailed description of the invention is hereafter described with specific reference being made to the drawings.



FIG. 1 is a side view of a distal portion of a stent delivery catheter positioned at a vessel bifurcation.



FIG. 2 is a side view of the catheter of FIG. 1 shown during initial delivery of a primary stent section of a bifurcated stent.



FIG. 3 is a side view of the catheter and bifurcated stent of FIG. 2 where the primary stent section is shown in the deployed state and a secondary stent section is shown in a predeployed state.



FIG. 4 is a side view of the catheter and bifurcated stent of FIG. 3 shown during initial delivery of the secondary stent section.



FIG. 5 is an enlarged side view of the catheter and stent shown in FIG. 4 wherein the primary and secondary stent sections are both shown in a deployed state.



FIG. 6 is a side view of a bifurcated stent delivery system that includes two substantially parallel balloons and guide wires.



FIG. 7 is a side view of a bifurcated stent delivery system wherein the catheter includes a restrictive band where the stent is disposed about both balloons.



FIG. 8 is a side view of a stent delivery system wherein the system includes a pair of angioplasty balloons.



FIG. 9 is a side view of the system of FIG. 6 is shown being positioned at a bifurcation site prior to stent delivery.



FIG. 10 is a side view of the system of claim 9 wherein a first balloon is shown inflated and a primary stent section is shown in an expanded state.



FIG. 11 is a side view of the system of claim 10 wherein a second balloon is shown inflated and a secondary stent section is shown in an expanded state.



FIG. 12 is a side view of the system shown in FIG. 11 wherein both balloons are inflated.



FIG. 13 is a side view of the system of claim 12 wherein the balloons are shown in an uninflated state prior to stent delivery and the sections of the bifurcated stent are shown in a deployed state.



FIG. 14 is an enlarged side view of a bifurcated stent wherein the stent sections are connected by one or more linkage members.



FIG. 15 is an enlarged side view of a bifurcated stent wherein the stent sections are connected by one or more linkage members.



FIG. 16 is a side view of a bifurcated stent wherein the stent sections are connected by an actuated linkage assembly.



FIG. 17 is a side view of a bifurcated stent wherein the primary stent section does not extend substantially beyond the carina when deployed.





DETAILED DESCRIPTION OF THE INVENTION

As indicated above the present invention includes many different embodiments. In some embodiments the invention is directed to various designs of bifurcated stents, their delivery systems and methods of use.


In FIG. 1 an embodiment of the invention is shown which comprises a bifurcated stent delivery system shown generally at 100. System 100 includes a catheter 10 that is advanced to a bifurcation site 20 along a primary guide wire 12 and a secondary guide wire 14. In use, the primary guide wire 12 and secondary guide wire 14 are advanced into a body lumen or vessel an advanced into the primary vessel 22. At the bifurcation site 20 the secondary guide wire 14 is directed into a secondary vessel 24 causing the guide wires 12 and 14 to diverge about the carina 26. Catheter 10 is advanced along the shared path of the guide wires 12 and 14 until it reaches the carina 26.


In order to accommodate the divergent path of the secondary guide wire 14, the catheter 10 includes a spilt area 30 where the secondary guide wire 14 exits the catheter 10. The spilt area 30 is a gap between two portions of the outer housing 32 of the catheter 10. The housing 32 may be characterized as a sheath, sleeve, sock or any other assembly suitable for retaining a stent in its collapsed state onto a stent receiving region of a catheter. Some examples of such stent retaining devices are described in U.S. Pat. No. 4,950,227 to Savin et al.; U.S. Pat. No. 5,403,341 to Solar; U.S. Pat. No. 5,108,416 to Ryan et al.; U.S. Pat. No. 5,968,069 to Dusbabek et al.; U.S. Pat. No. 6,068,634, to Cornelius et al.; U.S. Pat. Nos. 5,571,168; 5,733,267; 5,772,669; and 5,534,007 all of which are incorporated herein by reference in their entirety.


In the embodiment shown in FIG. 1, the housing 32 comprises a distal sleeve 34 and a proximal sleeve 36. As is more clearly shown in FIG. 2, sleeves 34 and 36 overlay a stent retaining region 38 of the catheter 10. Sleeves 34 and 36 may be self-retracting or include one or more pullback mechanisms (not-shown) such as are described in U.S. Pat. Nos. 5,571,135 and 5,445,646 both of which are incorporated herein by reference in their entirety.


In FIG. 1, the sleeves 34 and 36 overlay the bifurcated stent 50, shown in FIG. 2, which is disposed about a stent retaining region 38. Stent retaining region 38 may include a balloon or other inflatable area for use in expanding and/or seating stent 50. Stent 50 may be balloon expandable, self-expanding or a hybrid type stent.


In the embodiments shown in FIGS. 2-4, the bifurcated stent 50 comprises a primary stent section 52 and a secondary stent section 54. Preferably, both sections 52 and 54 are self-expanding stent bodies though the individual stent sections may have different expansion characteristics as desired. In addition, the sections 52 and 54 of the bifurcated stent 50 may be individual stent bodies that are separately advanced and deployed forming stent 50 once they are fully deployed, or they may be integrally formed or otherwise connected prior to their deployment.


In the embodiment shown in FIG. 2, the housing portions or sleeves 34 and 36 have been withdrawn from about the bifurcated stent 50. As the sleeves 34 and 36 are withdrawn from the primary stent section 52 will begin to radially expand in a center first manner through the split area 30. When the sleeves 34 and 36 are fully withdrawn, such as is shown in FIG. 3 the primary stent section 52 is completely freed from the stent retaining region 38.


If the stent section 52 and 54 are not integral to each other or otherwise linked prior to delivery, upon expansion of the primary section 52 the secondary section may be advanced along the secondary guide wire 14 and advanced to an opening 62 in the wall 64 of the primary stent section 52. Opening 62 may be any diameter or shape but preferably is sized to accommodate the outer diameter of the secondary stent section 54 as well as the inner diameter of the secondary vessel 24.


Whether the secondary stent section 54 is engaged to the primary stent section 52 or separate therefrom prior to deployment, when the secondary stent section 54 is in position at opening 62 and the primary section 52 has been expanded, the secondary stent section 54 is then deployed into the secondary vessel 24, such as is shown in FIG. 4. The position of the stent 50 at the bifurcation site maybe visually established through the use of a radiopaque marker 90, discussed in greater detail below.


In at least one embodiment, where the secondary stent section 54 is at least partially constructed from a shape memory material, such as nitinol, the secondary stent section 54 will self expand according to a preprogrammed shape memory, such that the section both radially and longitudinally expands into the secondary vessel 24. In some embodiments, catheter 10 may include a pusher assembly 70 that is advanced along the secondary guide wire 14 to trigger expansion of the secondary stent section 54. Pusher assembly 70 may provide a stimulus which causes the section 54 to expand. Such a stimulus may be in the form of a simple mechanical engagement; delivery of an electrical current; or delivery of a predetermined temperature and/or a predetermined pH, such as by the release of a heated saline bolus. In some embodiments, a separate balloon catheter or other inflation device may be advanced along the secondary guide wire 14 to fully expand and/or seat the secondary stent section 54.


When both stent sections 52 and 54 are fully deployed, such as is shown in FIG. 5, the proximal end of the secondary stent section 54 is preferably engaged to the wall 64 of the primary stent section 52. When fully deployed the primary stent section 52 defines a primary flow path 72 and the secondary stent section defines a secondary flow path 74 that is in fluid communication with the primary flow path via opening 62.


In an alternative embodiment of the invention, such as is shown in FIG. 6, system 100 may be provided with catheter 10 that is equipped with at least two balloons, a primary balloon 80 and a secondary balloon 82, which may be utilized for expansion and/or seating stent sections 52 and 54.


In the embodiment shown in FIG. 6, the bifurcated stent 50 may be constructed from stainless steel or other material that necessitates or would benefit from balloon expansion. As with previous embodiments, the catheter 10 includes a pair of guide wires 12 and 14 which are advanced to the bifurcation site 20 and which diverge at the carina 26 with the secondary guide wire 14 advancing into the secondary vessel 24.


In the embodiment shown in FIG. 6, during most of the advancement of the catheter 10 the balloons 80 and 82 are positioned together in the substantially parallel orientation shown. However, as the catheter 10 approaches the bifurcation site 20 the distal portion 86 of secondary balloon 82 and secondary stent section 54 are directed along the secondary guide wire 14 into the secondary vessel 24 as shown in FIG. 9.


In order to ensure that the bifurcated stent will provide adequate support to the vessels 22 and 24 of the bifurcation site, and particularly to the area of the carina 26, the catheter 10 may include a radiopaque marker 90. Marker 90 allows a practitioner to advance the catheter 10 to the bifurcation site 20 and visually determine through fluoroscopy or other means that the balloons 80 and 82 and stent sections 52 and 54 are properly positioned about the carina 26.


Marker 90 may be constructed from any radiopaque material and is preferably part of the bifurcated stent 50.


Once it is determined that the stent 50 is in proper position at the bifurcation site 20, the primary balloon 80 is inflated to expand the primary stent section 52 as shown in FIG. 10. After the initial expansion of the primary stent section 52, the secondary balloon 82 is inflated to initially expand the secondary stent 54 shown in FIG. 11.


In some embodiments it may be preferable to first deflate the primary balloon 80 before inflating the secondary balloon 82. In some embodiments where balloon 80 is deflated prior to inflation of balloon 82, balloon 80 may be subsequently inflated after inflation of balloon 82 to fully expand the stent and seat it in place within the bifurcation such as is shown in FIG. 12. Alternatively, balloons 80 and 82 may be inflated simultaneously.


Once both stent sections 52 and 54 are fully expanded, the balloons 80 and 82 are deflated and with drawn from the bifurcation site 20, such as is depicted in FIG. 13


Because some bifurcated stents may be subject to distortion or damage when over expanded or subjected to high radially outward acting pressure, in some embodiments, such as shown in FIG. 7, the proximal portion 88 of balloons 80 and 82, where both balloons are contained within the primary stent section 52, the catheter 10 may employ a circumferential band 92 that will limit the expandability of the proximal portion 88 of balloons 80 and 82, thereby preventing over inflation and over expansion of the primary stent portion 54 when both balloons are inflated. Band 92 may be constructed from any minimally or non-expandable material such as polyethyleneterephthalate (PET) or stainless steel.


In some applications, it may be beneficial or necessary to conduct an angioplasty procedure prior to insertion of the bifurcated stent 50. As a result, in at least one embodiment of the invention, an example of which is shown in FIG. 8, the catheter 10 may be equipped with a primary angioplasty balloon 94 and a secondary angioplasty balloon 96. In practice balloons 94 and 96 may be initially advanced to the bifurcation site 20 along guide wires 12 and 14 respectively. Upon reaching the bifurcation site 20, the balloons 94 and 96 may be inflated to reduce any stenosis or blockage 98 that may be present. After the blockage 98 is reduced, the balloons 94 and 96 may be deflated and advanced along the guide wires 12 and 14 into the respective vessels 22 and 24 thereby allowing balloons 80 and 82 to be positioned at the bifurcation site 20 to delivery the bifurcated stent 50.


In the embodiments shown in FIGS. 6-13, the bifurcated stent 50 may be a single piece design, where sections 52 and 54 are engaged to one another prior to and after delivery; or the stent 50 may be a two-piece design where both sections 52 and 54 are independent stent bodies that are separate prior to delivery and which may continue to be separate or which may become engaged to one another during or after delivery.


In embodiments where the stent 50 is a one-piece design, the stent sections may be engaged together by one or more linkage member 102 such as are shown in FIGS. 14-16. In FIGS. 14 and 15, the sections 52 and 54 are connected by at least 4 linkage members 102. In at least one embodiment, the sections 52 and 54 are connected by at least 8 linkage members 102. Linkage members 102 may be characterized as struts or connecting members 104 that are shared between sections 52 and 54. In a preferred embodiment, the members 102 are selectively annealed to provide the bifurcated stent 50 with improved flexibility between sections 52 and 54. By selectively annealing the members 102, the secondary stent section 52 may be articulated relative to the primary stent section 54 such that the bifurcated stent sections 52 and 54 may be provided with an angular relationship of about 90 degrees, indicated at reference numeral 106 in FIG. 15, or a more acute angle 108 shown in FIG. 14. By providing a bifurcated stent 50 that has sections 52 and 54 that may be oriented at a variety of angles, a single stent may be used to address a variety of different angular relationships between vessels of various bifurcation sites within a body. Preferably, the angular relationship between sections 52 and 54 defines an angle of about 10 degrees to about 120 degrees.


In at least one embodiment, the linkage members 102 are provided with a curvilinear or S-shaped configuration such as is best shown in FIG. 15. The S-shape of the linkage members aids in providing the bifurcated stent 50 with the ability to articulate about vessel junctions of various angles.


In at least one embodiment, shown in FIG. 16, the sections 52 and 54 of a bifurcated stent 50 are linked by a single linkage member 102. When inserted at a bifurcation site 20, the single linkage member is positioned at the carina 26 and acts as a hinge to allow the sections 52 and 54 to be disposed about the carina 26.


In at least one embodiment of the invention shown in FIG. 17, stent 50 includes a primary stent section 52 which does not extend distally beyond the carina 26. As a result the stent 50 may be advanced and positioned at the bifurcation site 20 by a singe guide wire 14 which extends into the secondary branch 24. Use of a marker 90 allows a practitioner to position the stent 50 by abutting the marker adjacent to the carina 26 and deploying the stent as shown. The stent 50 may include sections that are either balloon expandable, self-expandable, or hybrid expandable as desired. In the embodiment shown, primary stent section 52 is balloon expandable, and secondary stent section 54 is self-expandable.


In addition to being directed to the specific combinations of features claimed below, the invention is also directed to embodiments having other combinations of the dependent features claimed below and other combinations of the features described above.


The above disclosure is intended to be illustrative and not exhaustive. This description will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the claims where the term “comprising” means “including, but not limited to”. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims.


Further, the particular features presented in the dependent claims can be combined with each other in other manners within the scope of the invention such that the invention should be recognized as also specifically directed to other embodiments having any other possible combination of the features of the dependent claims. For instance, for purposes of claim publication, any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims). In jurisdictions where multiple dependent claim formats are restricted, the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claim below.

Claims
  • 1. A bifurcated stent, the bifurcated stent comprising: a primary stent section, the primary stent section being balloon expandable, the primary stent section having a tubular wall, a first end, and a second end, the first end defining a proximal opening, the second end defining a distal opening, the primary stent section being expanded from an unexpanded configuration to an expanded configuration, in the expanded configuration the primary stent section defining a primary flow path between the proximal opening and the distal opening, the tubular wall of the primary stent section defining a side branch opening; anda secondary stent section, the secondary stent section being self-expanding, an end of the secondary stent section being engaged to a portion of the tubular wall of the primary stent section defining the side branch opening, the secondary stent section having an unexpanded configuration and an expanded configuration, the secondary stent section having a first length in the unexpanded configuration, the secondary stent section having a second length in the expanded configuration, the first length less than the second length, the secondary stent section being expanded to the expanded configuration after the primary stent section is expanded to the expanded configuration, in the unexpanded configuration at least a portion of the secondary stent section forming a portion of the tubular wall of the primary stent section, in the expanded configuration the secondary stent section being positioned within a secondary vessel of the bifurcation site and defining a secondary flow path, the secondary flow path being in fluid communication with the primary flow path through the side branch opening.
  • 2. The bifurcated stent of claim 1, the end of the secondary stent section being removeably engaged to the portion of the tubular wall of the primary stent section defining the side branch opening.
  • 3. The bifurcated stent of claim 1, the secondary stent section and the primary stent section being integrally formed.
  • 4. The bifurcated stent of claim 1, the primary stent section having a first geometry, the secondary stent section having a second geometry, the first geometry different than the second geometry.
  • 5. The bifurcated stent of claim 1, further comprising a delivery system, the delivery system comprising a catheter, the catheter comprising: an expandable balloon, the bifurcated stent being disposed about the expandable balloon;a proximal housing and a distal housing, the proximal housing and the distal housing each having a closed configuration and open configuration, the proximal housing and the distal housing being immediately adjacent to one another to define a split region in the closed configuration, a portion of the proximal housing being disposed about a portion of the bifurcated stent in the closed configuration, a portion of the distal housing being disposed about a portion of the bifurcated stent in the closed configuration, the proximal housing and the distal housing in the open configuration being separated to enlarge the split region and expose the bifurcated stent;a secondary guide wire, the secondary guide wire being positioned between the bifurcated stent and the expandable balloon, the secondary guide wire extending through the split region into a secondary vessel to guide the secondary stent section into the secondary vessel; anda pusher mechanism, the pusher mechanism being engaged to the secondary guide wire, the pusher mechanism constructed and arranged to initiate expansion of the secondary stent section from the unexpanded configuration to the expanded configuration.
  • 6. The bifurcated stent of claim 5, the pusher mechanism providing at least one stimulus to the secondary stent section in the unexpanded state to initiate expansion, the at least one stimulus selected from the group consisting of a predetermined electric stimulus, a predetermined mechanical stimulus, a predetermined chemical stimulus, a predetermined temperature stimulus, and any combination thereof.
  • 7. The bifurcated stent of claim 5, wherein at least one of the proximal housing and the distal housing is selected from the group consisting of a retractable sleeve, retractable sheath, retractable sock, and any combination thereof.
  • 8. The bifurcated stent of claim 1, further comprising at least one radiopaque marker.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of Ser. No. 11/028,754, filed Jan. 3, 2005, which is a continuation of Ser. No. 10/083,711, filed Feb. 26, 2006, which claims priority from U.S. provisional applications 60/271,506 filed Feb. 26, 2001; U.S. provisional application 60/271,602 filed Feb. 26, 2001; and U.S. provisional application 60/271,595 filed Feb. 26, 2001; the entire content of each being incorporated herein by reference.

US Referenced Citations (238)
Number Name Date Kind
4309994 Grunwald Jan 1982 A
4769005 Ginsburg et al. Sep 1988 A
4774949 Fogarty Oct 1988 A
4896670 Crittenden Jan 1990 A
4905667 Foerster et al. Mar 1990 A
4994071 MacGregor Feb 1991 A
5342387 Summers Aug 1994 A
5387235 Chuter Feb 1995 A
5456712 Maginot Oct 1995 A
5476471 Shifrin et al. Dec 1995 A
5487730 Marcadis et al. Jan 1996 A
5562641 Flomenblit et al. Oct 1996 A
5591228 Edoga Jan 1997 A
5607444 Lam Mar 1997 A
5609605 Marshall et al. Mar 1997 A
5609627 Goicoechea et al. Mar 1997 A
5613980 Chauhan Mar 1997 A
5617878 Taheri Apr 1997 A
5632762 Myler May 1997 A
5632763 Glastra May 1997 A
5632772 Alcime et al. May 1997 A
5636641 Fariabi Jun 1997 A
5653743 Martin Aug 1997 A
5669924 Shaknovich Sep 1997 A
5669932 Fischell et al. Sep 1997 A
5676697 McDonald Oct 1997 A
5683450 Goicoechea et al. Nov 1997 A
5697971 Fischell et al. Dec 1997 A
5707348 Krogh Jan 1998 A
5709713 Evans et al. Jan 1998 A
5720735 Dorros Feb 1998 A
5725519 Penner et al. Mar 1998 A
5749825 Fischell et al. May 1998 A
5749890 Shaknovich May 1998 A
5755734 Richter et al. May 1998 A
5755735 Richter et al. May 1998 A
5755771 Penn et al. May 1998 A
5755773 Evans et al. May 1998 A
5755778 Kleshinski May 1998 A
5782906 Marshall et al. Jul 1998 A
5824036 Lauterjung Oct 1998 A
5824040 Cox et al. Oct 1998 A
5827320 Richter et al. Oct 1998 A
5851464 Davila et al. Dec 1998 A
5868777 Lam Feb 1999 A
5893887 Jayaraman Apr 1999 A
5961548 Shmulewitz Oct 1999 A
5972017 Berg et al. Oct 1999 A
6013054 Jium Yan Jan 2000 A
6017324 Tu et al. Jan 2000 A
6017363 Hojeibane Jan 2000 A
6030414 Taheri Feb 2000 A
6033434 Borghi Mar 2000 A
6033435 Penn et al. Mar 2000 A
6056775 Borghi et al. May 2000 A
6059824 Taheri May 2000 A
6068655 Seguin et al. May 2000 A
6071298 Lashinski Jun 2000 A
6086611 Duffy et al. Jul 2000 A
6093203 Uflacker Jul 2000 A
6096073 Webster et al. Aug 2000 A
6099497 Adams et al. Aug 2000 A
6113579 Eidenschink et al. Sep 2000 A
6117117 Mauch Sep 2000 A
6117156 Richter et al. Sep 2000 A
6129738 Lashinski et al. Oct 2000 A
6129756 Kugler et al. Oct 2000 A
6142973 Carleton et al. Nov 2000 A
6143002 Vietmeier Nov 2000 A
6159238 Killion et al. Dec 2000 A
6165195 Wilson et al. Dec 2000 A
6168621 Vrba Jan 2001 B1
6183509 Dibie Feb 2001 B1
6197049 Shaolian et al. Mar 2001 B1
6203568 Lombardi et al. Mar 2001 B1
6210380 Mauch Apr 2001 B1
6210429 Vardi et al. Apr 2001 B1
6210433 Larre Apr 2001 B1
6221098 Wilson et al. Apr 2001 B1
6254593 Wilson Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6258116 Hojeibane Jul 2001 B1
6261305 Marotta et al. Jul 2001 B1
6261316 Shaolian et al. Jul 2001 B1
6264662 Lauterjung Jul 2001 B1
6264686 Rieu et al. Jul 2001 B1
6287335 Drasler et al. Sep 2001 B1
6290673 Shanley Sep 2001 B1
6293967 Shanley Sep 2001 B1
6293968 Taheri Sep 2001 B1
6325822 Vardi et al. Dec 2001 B1
6325826 Vardi et al. Dec 2001 B1
6334864 Amplatz et al. Jan 2002 B1
6346089 Dibie Feb 2002 B1
6355060 Lenker et al. Mar 2002 B1
6361544 Wilson et al. Mar 2002 B1
6361555 Wilson Mar 2002 B1
6383213 Wilson et al. May 2002 B2
6387120 Wilson et al. May 2002 B2
6395018 Castaneda May 2002 B1
6432130 Hanson Aug 2002 B1
6436104 Hojeibane Aug 2002 B2
6436134 Richter et al. Aug 2002 B2
6468301 Amplatz et al. Oct 2002 B1
6508836 Wilson et al. Jan 2003 B2
6517558 Gittings et al. Feb 2003 B2
6520988 Colombo et al. Feb 2003 B1
6540779 Richter et al. Apr 2003 B2
6579309 Loos et al. Jun 2003 B1
6579312 Wilson et al. Jun 2003 B2
6582394 Reiss et al. Jun 2003 B1
6596020 Vardi et al. Jul 2003 B2
6599319 Vardi et al. Jul 2003 B2
6623450 Dutta Sep 2003 B1
6645242 Quinn Nov 2003 B1
6673107 Brandt et al. Jan 2004 B1
6689156 Davidson et al. Feb 2004 B1
6692483 Vardi et al. Feb 2004 B2
6695877 Brucker et al. Feb 2004 B2
6706062 Vardi et al. Mar 2004 B2
6749628 Callol et al. Jun 2004 B1
6761734 Suhr Jul 2004 B2
6776793 Brown et al. Aug 2004 B2
6811566 Penn et al. Nov 2004 B1
6835203 Vardi et al. Dec 2004 B1
6858038 Heuser Feb 2005 B2
6884258 Vardi et al. Apr 2005 B2
6890349 McGuckin et al. May 2005 B2
6896699 Wilson et al. May 2005 B2
6932837 Amplatz et al. Aug 2005 B2
6945995 Nicholas Sep 2005 B2
6955687 Richter et al. Oct 2005 B2
6955688 Wilson et al. Oct 2005 B2
6962602 Vardi et al. Nov 2005 B2
7018400 Lashinski et al. Mar 2006 B2
7056323 Mareiro et al. Jun 2006 B2
7060091 Killion et al. Jun 2006 B2
7220275 Davidson et al. May 2007 B2
20010002443 Parodi May 2001 A1
20010002927 Detampel Jun 2001 A1
20010002943 Nagayama et al. Jun 2001 A1
20010003161 Vardi et al. Jun 2001 A1
20010004705 Killion et al. Jun 2001 A1
20010004706 Hojeibane Jun 2001 A1
20010004707 Dereume et al. Jun 2001 A1
20010004823 Cronin et al. Jun 2001 A1
20010007954 Shaolian et al. Jul 2001 A1
20010012927 Mauch Aug 2001 A1
20010016766 Vardi et al. Aug 2001 A1
20010016767 Wilson et al. Aug 2001 A1
20010016768 Wilson et al. Aug 2001 A1
20010020173 Klumb et al. Sep 2001 A1
20010020184 Dehdashtian et al. Sep 2001 A1
20010025195 Shaolian et al. Sep 2001 A1
20010027291 Shanley Oct 2001 A1
20010027338 Greenberg Oct 2001 A1
20010029396 Wilson et al. Oct 2001 A1
20010037116 Wilson et al. Nov 2001 A1
20010037138 Wilson et al. Nov 2001 A1
20010039448 Dibie Nov 2001 A1
20010049552 Richter et al. Dec 2001 A1
20010056297 Hojeibane Dec 2001 A1
20020013618 Marotta et al. Jan 2002 A1
20020013619 Shanley Jan 2002 A1
20020022874 Wilson Feb 2002 A1
20020026232 Marotta et al. Feb 2002 A1
20020035392 Wilson Mar 2002 A1
20020042650 Vardi et al. Apr 2002 A1
20020052648 McGuckin et al. May 2002 A1
20020072790 McGuckin, Jr. et al. Jun 2002 A1
20020111675 Wilson Aug 2002 A1
20020156516 Vardi et al. Oct 2002 A1
20020156517 Perouse Oct 2002 A1
20020165604 Shanley Nov 2002 A1
20020173835 Bourang et al. Nov 2002 A1
20020173840 Brucker et al. Nov 2002 A1
20020183763 Callol et al. Dec 2002 A1
20020193872 Trout, III et al. Dec 2002 A1
20020193873 Brucker et al. Dec 2002 A1
20030009209 Hojeibane Jan 2003 A1
20030028233 Vardi et al. Feb 2003 A1
20030050688 Fischell et al. Mar 2003 A1
20030055378 Wang et al. Mar 2003 A1
20030055483 Gumm Mar 2003 A1
20030074047 Richter Apr 2003 A1
20030093109 Mauch May 2003 A1
20030097169 Brucker May 2003 A1
20030114912 Sequin et al. Jun 2003 A1
20030125791 Sequin et al. Jul 2003 A1
20030125802 Callol et al. Jul 2003 A1
20030135259 Simso Jul 2003 A1
20030181923 Vardi Sep 2003 A1
20030191516 Weldon et al. Oct 2003 A1
20030195606 Davidson et al. Oct 2003 A1
20040006381 Sequin et al. Jan 2004 A1
20040015227 Vardi et al. Jan 2004 A1
20040044396 Clerc et al. Mar 2004 A1
20040044398 Nicholas Mar 2004 A1
20040059406 Cully et al. Mar 2004 A1
20040088007 Eidenschink May 2004 A1
20040098081 Landreville et al. May 2004 A1
20040117003 Ouriel et al. Jun 2004 A1
20040133268 Davidson et al. Jul 2004 A1
20040138732 Suhr et al. Jul 2004 A1
20040138737 Davidson et al. Jul 2004 A1
20040148006 Davidson et al. Jul 2004 A1
20040172121 Eidenschink et al. Sep 2004 A1
20040186560 Alt Sep 2004 A1
20040225345 Fischell et al. Nov 2004 A1
20040267352 Davidson et al. Dec 2004 A1
20050004656 Das Jan 2005 A1
20050010276 Acosta et al. Jan 2005 A1
20050010278 Vardi et al. Jan 2005 A1
20050015108 Williams et al. Jan 2005 A1
20050015135 Shanley Jan 2005 A1
20050060027 Khenansho et al. Mar 2005 A1
20050080474 Andreas et al. Apr 2005 A1
20050096723 Sequin et al. May 2005 A1
20050102021 Osborne May 2005 A1
20050102023 Yadin et al. May 2005 A1
20050119731 Brucker et al. Jun 2005 A1
20050125076 Ginn Jun 2005 A1
20050131526 Wong Jun 2005 A1
20050149161 Eidenschink et al. Jul 2005 A1
20050154442 Eidenschink et al. Jul 2005 A1
20050154444 Quadri Jul 2005 A1
20050183259 Eidenschink et al. Aug 2005 A1
20050209673 Shaked Sep 2005 A1
20050228483 Kaplan et al. Oct 2005 A1
20060036315 Yadin et al. Feb 2006 A1
20060041303 Israel Feb 2006 A1
20060079956 Eigler et al. Apr 2006 A1
20060173528 Feld et al. Aug 2006 A1
20070073376 Krolik et al. Mar 2007 A1
20070112418 Eidenschink et al. May 2007 A1
20070112419 Yadin May 2007 A1
20070135904 Eidenschink et al. Jun 2007 A1
20070168011 LaDuca et al. Jul 2007 A1
Foreign Referenced Citations (125)
Number Date Country
2220864 Jul 1999 CA
9014845 Feb 1991 DE
2970883 Mar 1997 DE
29701758 May 1997 DE
0479730 Oct 1991 EP
0686379 Dec 1995 EP
0751752 Jan 1997 EP
0783873 Jul 1997 EP
0804907 Nov 1997 EP
0479557 Jul 1998 EP
0876805 Nov 1998 EP
0647148 Dec 1998 EP
0880949 Dec 1998 EP
0891751 Jan 1999 EP
0895759 Feb 1999 EP
0897700 Feb 1999 EP
0904745 Mar 1999 EP
0937442 Aug 1999 EP
0347023 Dec 1999 EP
1031328 Aug 2000 EP
1031329 Aug 2000 EP
1031330 Aug 2000 EP
0883384 Dec 2000 EP
0862392 Aug 2001 EP
0808140 Dec 2001 EP
0884028 Feb 2002 EP
1190685 Mar 2002 EP
0684022 Feb 2004 EP
1157674 Jul 2005 EP
1070513 Jun 2006 EP
2678508 Jul 1991 FR
2740346 Oct 1995 FR
2756173 Nov 1996 FR
2760351 Mar 1997 FR
2337002 May 1998 GB
8806026 Aug 1988 WO
9510442 Apr 1995 WO
WO 9514442 Jun 1995 WO
9521592 Aug 1995 WO
9629955 Oct 1996 WO
9634580 Nov 1996 WO
9641592 Dec 1996 WO
9707752 Mar 1997 WO
9715346 May 1997 WO
9716217 May 1997 WO
9726936 Jul 1997 WO
9741803 Nov 1997 WO
9745073 Dec 1997 WO
9746174 Dec 1997 WO
9819628 May 1998 WO
9836709 Aug 1998 WO
9837833 Sep 1998 WO
9847446 Oct 1998 WO
9847447 Oct 1998 WO
9848879 Nov 1998 WO
9853759 Dec 1998 WO
9903426 Jan 1999 WO
9903462 Jan 1999 WO
9904726 Feb 1999 WO
9913808 Mar 1999 WO
9915103 Apr 1999 WO
9915108 Apr 1999 WO
9915109 Apr 1999 WO
9924104 May 1999 WO
9934749 Jul 1999 WO
9936002 Jul 1999 WO
9936015 Jul 1999 WO
9944539 Sep 1999 WO
9956661 Nov 1999 WO
9965419 Dec 1999 WO
0007523 Feb 2000 WO
0010485 Mar 2000 WO
0010489 Mar 2000 WO
0013613 Mar 2000 WO
0016719 Mar 2000 WO
0027307 May 2000 WO
0027463 May 2000 WO
0028922 May 2000 WO
0032266 Jun 2000 WO
0044307 Aug 2000 WO
0044309 Aug 2000 WO
0047134 Aug 2000 WO
0048531 Aug 2000 WO
0049951 Aug 2000 WO
0051523 Sep 2000 WO
0057813 Oct 2000 WO
0071054 Nov 2000 WO
0067673 Nov 2000 WO
0071055 Nov 2000 WO
0074595 Dec 2000 WO
0121095 Mar 2001 WO
0121109 Mar 2001 WO
0121244 May 2001 WO
0130433 May 2001 WO
0135715 May 2001 WO
0135863 May 2001 WO
0139697 Jun 2001 WO
0139699 Jun 2001 WO
0141677 Jun 2001 WO
0143665 Jun 2001 WO
0143809 Jun 2001 WO
0145594 Jun 2001 WO
0145785 Jun 2001 WO
0149342 Jul 2001 WO
0154621 Aug 2001 WO
0154622 Aug 2001 WO
0158385 Aug 2001 WO
0160284 Aug 2001 WO
0170294 Sep 2001 WO
0170299 Sep 2001 WO
0174273 Oct 2001 WO
0189409 Nov 2001 WO
0200138 Jan 2002 WO
WO 0239888 May 2002 WO
WO 0239926 May 2002 WO
02053066 Jul 2002 WO
02068012 Sep 2002 WO
03007842 Jan 2003 WO
03055414 Jul 2003 WO
03063924 Aug 2003 WO
2004026174 Apr 2004 WO
2004026180 Apr 2004 WO
2005009295 Feb 2005 WO
2005014077 Feb 2005 WO
2006028925 Mar 2006 WO
Related Publications (1)
Number Date Country
20070168020 A1 Jul 2007 US
Provisional Applications (3)
Number Date Country
60271506 Feb 2001 US
60271602 Feb 2001 US
60271595 Feb 2001 US
Continuations (2)
Number Date Country
Parent 11028754 Jan 2005 US
Child 11726144 US
Parent 10083711 Feb 2002 US
Child 11028754 US